Pyruvate-enriched Preservation of Machine Perfused Kidneys

Simple item page
dc.contributor.advisorMallet, Robert T.
dc.contributor.committeeMemberOlivencia-Yurvati, Albert H.
dc.contributor.committeeMemberRomero, Steven A.
dc.creatorOmar, Salma K.
dc.date.accessioned2020-04-22T19:28:53Z
dc.date.available2020-04-22T19:28:53Z
dc.date.issued2020-05
dc.description.abstractPurpose: Kidney transplantation remains the gold-standard treatment for patients diagnosed with end-stage renal disease (ESRD). However, the demand for donors currently far outpaces the supply. Kidneys donated after cardiac death (DCD) are a promising source, as cardiac arrest remains the leading cause of death in the United States. Studies have demonstrated the efficacy of hypothermic machine perfusion (HMP), a process by which kidneys are cannulated and perfused with a pulsatile flowing solution under hypothermic conditions, in reducing insult to organs compared to standard static cold storage (SCS) [1-3]. To date, perfusate additives to further optimize the outcomes of HMP preserved kidneys have not been extensively studied. The glycolytic end product, pyruvate, has demonstrated efficacy with protecting the heart from ischemia-reperfusion injury, improving post-ischemic contractile function of the heart through its function as an antioxidant and energy substrate, maintaining the glutathione redox state, and inducing erythropoietin production [4, 5]. We aim to investigate the impact of pyruvate on DCD kidneys maintained under HMP conditions. Methods: Cardiovascular death and a period of warm ischemia will be induced in a large animal model, the domestic pig. After explant, one kidney will serve as a pre-perfusion control and the other will be immediately flushed and cannulated to the HMP apparatus. The solutions perfusing the kidney in the HMP machine will consist of either a control perfusate or a pyruvate-enriched perfusate. Sample of the perfusate will be drawn periodically and cytokine concentration will be quantified. Tissue samples from the pre-perfused and 72-hour post-perfusion kidneys will be taken evaluated for both changes in renal tissue integrity via histological assessment and mRNA concentrations of various cytokines. Results: In pyruvate treated DCD kidneys, both renal cortex and renal medulla samples demonstrated better preserved tissue integrity compared to control. Additionally, markers for pro-inflammatory response markedly increased in the control group compared to the treatment group and vice versa for anti-inflammatory markers, including erythropoietin. Conclusions: We expect pyruvate preserved DCD kidneys will experience improved preservation by dampening the rate of increase of pro-inflammatory markers and increasing the concentration of anti-inflammatory markers.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/20.500.12503/29839
dc.language.isoen
dc.subjectdeceased after cardiac death (DCD) kidneys
dc.subjecthypothermic machine perfusion (HMP)
dc.subjectkidney transplant
dc.subjectporcine
dc.subjectpyruvate
dc.subject.meshKidney Transplantation / methods
dc.subject.meshOrgan Preservation / methods
dc.subject.meshPerfusion / methods
dc.subject.meshPyruvic Acid / metabolism
dc.subject.meshDisease Models, Animal
dc.subject.meshHypothermia, Induced / methods
dc.titlePyruvate-enriched Preservation of Machine Perfused Kidneys
dc.typeThesis
dc.type.materialtext
thesis.degree.departmentGraduate School of Biomedical Sciences
thesis.degree.disciplineIntegrative Physiology
thesis.degree.grantorUniversity of North Texas Health Science Center at Fort Worth
thesis.degree.nameMaster of Science

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2020_05_gsbs_Omar_Salma_practicum.pdf
Size:
1.73 MB
Format:
Adobe Portable Document Format
Description:
Download

Collections

School of Biomedical Sciences
Theses and Dissertations